AI-designed drug appears to turn back the body's biological clock in early trial

A study in Nature Biotechnology suggests that rentosertib, a drug designed with AI by Insilico Medicine, may reverse markers of biological aging. Six independent aging clocks predicted that treated patients were biologically up to six years younger than the placebo group. The…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on The Decoder.